1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,000 | 07:31 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | XFRA 56R1: AUSSETZUNG/SUSPENSION | 410 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNANOVIBRONIX NEW... ► Artikel lesen | |
| Di | XFRA NEW INSTRUMENTS AVAILABLE ON 12.08.2025 | 129 | Xetra Newsboard | The following instruments on XETRA do have their first trading 12.08.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.08.2025
Aktien
1 CA00810E2087 Aether Global Innovations... ► Artikel lesen | |
| 11.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.08.2025 | 402 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 11.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.08.2025.ISIN NameAU000000EVS3 ENVIROSUITE... ► Artikel lesen | |
| 11.08. | XFRA ISIN CHANGE | 158 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA00810E1097 Aether Global Innovations Corp. 11.08.2025 CA00810E2087 Aether Global Innovations Corp. 12.08.2025 Tausch... ► Artikel lesen | |
| 08.08. | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.08. | NanoVibronix announces another reverse stock split | 4 | MassDevice | ||
| 08.08. | NanoVibronix announces 1-for-10 reverse stock split effective August 11 | 6 | Investing.com | ||
| 08.08. | NanoVibronix, Inc. Announces Reverse Stock Split | 128 | Business Wire | Common Stock Will Begin Trading on Split-Adjusted Basis on August 12, 2025
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) ("NanoVibronix" or the "Company"), a medical technology... ► Artikel lesen | |
| NANOVIBRONIX Aktie jetzt für 0€ handeln | |||||
| 30.07. | NanoVibronix, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.07. | NanoVibronix-Aktionäre geben grünes Licht für Aktienzusammenlegung | 12 | Investing.com Deutsch | ||
| 18.07. | NanoVibronix, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 18.07. | NanoVibronix enters into $50M financing agreement | 2 | MassDevice | ||
| 18.07. | NanoVibronix sichert sich Finanzierung über 8 Millionen US-Dollar mit Option auf Aufstockung | 2 | Investing.com Deutsch | ||
| 18.07. | NanoVibronix secures $8 million in funding, with potential for more | 1 | Investing.com | ||
| 11.07. | NanoVibronix vertagt außerordentliche Hauptversammlung mangels Beschlussfähigkeit | 4 | Investing.com Deutsch | ||
| 09.07. | NanoVibronix korrigiert Mindestpreis für Vorzugsaktien der Serie G | 2 | Investing.com Deutsch | ||
| 09.07. | NanoVibronix, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.06. | Pre-market Movers: Blue Gold, INmune Bio, Cyngn, NanoVibronix, GlucoTrack | 794 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.20 A.M. ET).In the Green Blue Gold Limited (BGL) is up over 297% at $80.01.
INmune... ► Artikel lesen | |
| 26.06. | NanoVibronix has a next-gen robotic system under development | 20 | MassDevice | ||
| 11.06. | NanoVibronix erhält US-Patent für pädiatrisches Ernährungssondensystem | 16 | Investing.com Deutsch |
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,850 | -0,47 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,118 | -2,48 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| BECTON DICKINSON | 167,05 | -0,27 % | NSE - BECTON DICKINSON & CO - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NUGEN MEDICAL DEVICES | 0,033 | +3,80 % | Beaking News: Vive la InsuJet - mit der Krankenkasse zum Erfolg? | ||
| ATOSSA THERAPEUTICS | 0,682 | +2,10 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Corporate Update | FDA Provides Positive Feedback, Clears Path for Atossa to File IND for (Z)-Endoxifen in Metastatic Breast Cancer; FDA Indicates No Additional Toxicity Studies Required
Strong... ► Artikel lesen | |
| SPINEWAY | 0,130 | +2,36 % | Spineway: H1 2025 results - Continued improvement in results and financial position | Press release Ecully, July 30, 2025 - 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,690 | +0,36 % | HSI Closes Midday at 24,929, Up 22 pts; HSTI Closes Midday at 5,438, Down 21 pts; KUAISHOU-W Down over 6%; CH MODERN D, BRILLIANCE CHI, YOURAN DAIRY, PA GOODDOCTOR, REALORD GROUP Hit New Highs | ||
| MOUNTAIN VALLEY MD | 0,011 | -13,64 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,268 | +7,20 % | Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results | SALT LAKE CITY, Aug. 14, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| CYTOSORBENTS | 0,941 | -4,27 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., Aug. 7, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 2,861 | -4,39 % | XFRA NEW INSTRUMENTS AVAILABLE ON 11.08.2025 | The following instruments on XETRA do have their first trading 11.08.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 11.08.2025
Aktien
1 US14843C1053 Castle Biosciences Inc.
2... ► Artikel lesen | |
| LIFEWARD | 0,630 | 0,00 % | Lifeward Ltd.: Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update | Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in ChinaGranted orphan drug designation from the European Medicines... ► Artikel lesen | |
| VOLITIONRX | 0,677 | 0,00 % | VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Friday, August 15 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., Aug. 14, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
| EKSO BIONICS | 3,120 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen |
NANOVIBRONIX INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,620 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOVIBRONIX INC finden Sie auf Wallstreet Online.